BioSpectrum Asia

Two multi-institution and multidisciplinary #Singapore teams of clinician-scientists and researchers have been awarded grants of S$25 million each, by the Ministry of Health (Singapore) through the NMRC Office, MOH Holdings, under the NMRC Open Fund-Large Collaborative Grant (OF-LCG) programme. #oncologyresearch #innovativetreatmentmodalities #collaboration #diagnosis https://lnkd.in/dA2CzaxG

Biocon, an innovation-led global biopharmaceutical company headquartered in India, has announced the signing of an exclusive licensing and supply agreement with HANDOK, a specialty pharmaceutical company in South Korea, for the commercialisation of its vertically integrated, complex drug product, Synthetic Liraglutide. #drugdevelopment #diagnosis #clinicaltrials #strategicpartnership #chronicweightmanagement https://lnkd.in/dvzdM_cy

#ExpertInsight Achieving optimal therapeutic modalities for NCDs in the APMA region https://lnkd.in/ghJUVRHY BioSpectrum Asia in an Insightful conversation with "Iris Zemzoum, President of Novartis Asia Pacific, Middle East and Africa (APMA)"

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, has announced the groundbreaking of its new R&D and manufacturing site in #Singapore. #manufacturingservices #healthcaretreatments #syntheticconjugates #commercialisation  https://lnkd.in/gsmeNfnt

A team of researchers led by Associate Professor Alfredo FRANCO-Obregón from the iHealthtech, National University of Singapore, has unveiled a novel approach to stimulate muscle, by way of using brief and mild pulsed electromagnetic field exposure, to produce and release proteins possessing anti-cancer properties. #anticancerproperties #magneticstimulation #chemicalmolecules #drugdevelopment #cancercare https://lnkd.in/grmJ78aM

According to the '2024 Global Hepatitis Report' by the World Health Organization, the number of lives lost due to viral hepatitis is increasing year by year, leading to 1.3 million deaths in 2022, claiming 3,500 lives each day in average, and resulting in it constituting the second leading cause of infectious disease deaths worldwide. #earlydetection #humanhealth #startups #clinicalresearch #ultrasoundimagingdevice https://lnkd.in/d4Si3NGH

How APAC Has Turned into Clinical Trial Behemoth From being a consistent participant in #clinicaltrial conduct worldwide, the APAC has emerged as a major power. A number of causes, including the region's thriving drug development innovation and the ongoing presence of international pharmaceutical corporations conducting multi-regional studies, are driving this growth. More details on this by Mohammad I. Global Head, Business Development & Operation, 3H Medi Solution Inc, Japan. Manbeena Chawla Ph.D. https://lnkd.in/dw88DeKs

BioSpectrum Asia is proud to announce our partnership with the World Vaccine Congress Europe! This World-leading vaccine congress will be taking place in Barcelona, Spain, 28 th - 31 st of October. This 4 day event will host 3,000+ attendees, 280 speakers, and 150+ exhibitors, with start-ups included as well! This global event brings together all aspects of Vaccine R&D with the opportunity to speak and network with industry leading individuals. Register now to find out more! Click the link here https://lnkd.in/d9DrKkCB Use discount code BSA20 to save an additional 20% off the Standard and/ or Pharma/Biotech packages! #WVCEU #WorldVaccineCongress #biopharmaevents #pharmaevents #networkingevents Saradha Mani

British multinational pharmaceutical company AstraZeneca intends to build a $1.5 billion manufacturing facility in #Singapore for antibody drug conjugates (ADCs), enhancing global supply of its ADC portfolio.  #manufacturingfacility #drugdiscovery #biopharmaceutical #economicopportunities https://lnkd.in/dZ7nYaBg

Hoya Group Company, PENTAX of America, Inc. (PENTAX Medical, a division of HOYA Group) and Magentiq Eye Ltd. , an artificial intelligence (AI)-based medical device company, have announced their intention to form a partnership in the field of AI in Gastroenterology and to examine further collaboration and strategic partnerships. #medicaldevices #diagnosticcapabilities #endoscopicAI #milestone #colonoscopies https://lnkd.in/dSJ9aUp3